Patents by Inventor Shih Hsin Wu

Shih Hsin Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Single nucleotide polymorphisms in protein-tyrosine phosphatase receptor-type delta for the diagnosis of susceptibility to asthma
    Patent number: 7604945
    Abstract: A gene related to a susceptibility of infection and asthma—the Protein-Tyrosine Phosphatase Receptor-type Delta (PTPRD) gene—a method of detecting the asthma-associated gene, a method of predicting the occurrence of asthma, a method of identifying asthma-associated alleles in PTPRD gene, a method of screening PTPRD for drugs useful in the treatment of asthma, and antibodies specific for PTPRD variants and their use in diagnostic assays.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: October 20, 2009
    Assignee: Vita Genomics, Inc.
    Inventors: Shih Hsin Wu, Ellson Ye-Shyon Chen
  • Single Nucleotide Polymorphisms in Protein-Tyrosine Phosphatase Receptor-Type Delta for the Diagnosis of Susceptibility to Infection and Asthma
    Publication number: 20080187932
    Abstract: A gene related to a susceptibility of infection and asthma—the Protein-Tyrosine Phosphatase Receptor-type Delta (PTPRD) gene—a method of detecting the asthma-associated gene, a method of predicting the occurrence of asthma, a method of identifying asthma-associated alleles in PTPRD gene, a method of screening PTPRD for drugs useful in the treatment of asthma, and antibodies specific for PTPRD variants and their use in diagnostic assays.
    Type: Application
    Filed: January 23, 2008
    Publication date: August 7, 2008
    Applicant: Vita Genomics, Inc.
    Inventors: Shih Hsin Wu, Ellson Ye-Shyon Chen
  • Model and modeling for predicting a hepatitis B patient to response to interferon treatment
    Publication number: 20040265832
    Abstract: By genotyping analysis in combination with Monte-Carlo estimation, a model for predicting an hepatitis B patient to response to interferon treatment is constructed. With this model, by selecting STR markers combination, the hepatitis B patients are divided into three groups comprising high response rate, ambiguous, and low response rate, respectively, and hence, predictions of treatment response for HBV patients, especially for interferon therapy, are obtained.
    Type: Application
    Filed: June 24, 2003
    Publication date: December 30, 2004
    Inventors: Lawrence Shih Hsin Wu, Lichih Huang, Cherry Guan Ju Lin, Julia Kuei Ting Yu, Ding-Shinn Chen, Pei-Jer Chen, Ming-Yang Lai, Shiou-Hwei Yeh